A dimerized urea-based inhibitor of the prostate-specific membrane antigen for 68Ga-PET imaging of prostate cancer

Overview of attention for article published in EJNMMI Research, June 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

patent: 7 patents

Citations

dimensions_citation: 146 Dimensions

Readers on

mendeley: 108 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 7 patents that reference this research output.

Double-labeled probe for molecular imaging and use thereof

Grant US-11638765-B2

United States of America

Double-labeled probe for molecular imaging and use thereof

Grant US-11452786-B2

United States of America

PSMA-TARGETING CONJUGATE AND USES THEREOF

Application WO-2022157119-A1

World Intellectual Property Organisation (WIPO)

PSMA-TARGETING CONJUGATE AND USES THEREOF

Application EP-4029523-A1

European Patent Office

Urea-based prostate specific membrane antigen (PSMA) inhibitors for imaging and therapy

Grant US-10688200-B2

United States of America

Double-labeled probe for molecular imaging and use thereof

Application US-10406246-B2

United States of America

HBED-bisphosphonates, radiometal conjugates and their use as theranostic agents

Application US-10253052-B2

United States of America